
Fred H. Reynolds
Examiner (ID: 8556, Phone: (571)270-7214 , Office: P/1675 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1658, 1675 |
| Total Applications | 1158 |
| Issued Applications | 386 |
| Pending Applications | 177 |
| Abandoned Applications | 614 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17561736
[patent_doc_number] => 20220125885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => GLUCAGON ANALOG AGONISTS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/427782
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427782 | GLUCAGON ANALOG AGONISTS AND METHODS OF USING THE SAME | Jan 28, 2020 | Abandoned |
Array
(
[id] => 15931051
[patent_doc_number] => 20200157159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => PEPTIDE COMPOUNDS AND COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/775877
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775877
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/775877 | PEPTIDE COMPOUNDS AND COMPOSITIONS THEREOF | Jan 28, 2020 | Abandoned |
Array
(
[id] => 16206533
[patent_doc_number] => 20200239523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/774686
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774686
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/774686 | NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS | Jan 27, 2020 | Abandoned |
Array
(
[id] => 17407155
[patent_doc_number] => 11248024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Noxa-derived, cell death-inducing peptide eMTD
[patent_app_type] => utility
[patent_app_number] => 16/774423
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 6556
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774423
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/774423 | Noxa-derived, cell death-inducing peptide eMTD | Jan 27, 2020 | Issued |
Array
(
[id] => 17272994
[patent_doc_number] => 20210379192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => SKELETAL MUSCLE TARGETING MOIETIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/300507
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/300507 | SKELETAL MUSCLE TARGETING MOIETIES AND USES THEREOF | Jan 26, 2020 | Abandoned |
Array
(
[id] => 16341720
[patent_doc_number] => 20200306370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => AMINO ACID AND PEPTIDE CONJUGATES AND CONJUGATION PROCESS
[patent_app_type] => utility
[patent_app_number] => 16/773241
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773241
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773241 | AMINO ACID AND PEPTIDE CONJUGATES AND CONJUGATION PROCESS | Jan 26, 2020 | Abandoned |
Array
(
[id] => 16190792
[patent_doc_number] => 20200231641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => METHODS AND COMPOSITIONS FOR VISUALIZING SUMO
[patent_app_type] => utility
[patent_app_number] => 16/744889
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744889 | METHODS AND COMPOSITIONS FOR VISUALIZING SUMO | Jan 15, 2020 | Abandoned |
| 16/742195 | PEPTIDE, COMPOSITION AND METHOD FOR ANTI-HAIR GRAYING | Jan 13, 2020 | Abandoned |
Array
(
[id] => 17029711
[patent_doc_number] => 11091516
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Synthetic binder of breast cancer stem cells
[patent_app_type] => utility
[patent_app_number] => 16/739516
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 34
[patent_no_of_words] => 23095
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739516
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739516 | Synthetic binder of breast cancer stem cells | Jan 9, 2020 | Issued |
Array
(
[id] => 16504860
[patent_doc_number] => 20200384116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => SELF-ASSEMBLING VERTEPORFIN AMPHIPHILES (SAVA) FOR LOCAL CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/739956
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739956 | SELF-ASSEMBLING VERTEPORFIN AMPHIPHILES (SAVA) FOR LOCAL CANCER THERAPY | Jan 9, 2020 | Abandoned |
Array
(
[id] => 18902705
[patent_doc_number] => 20240018190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => CONDUCTIVE SYNTHETIC PEPTIDES FOR MOLECULAR ELECTRONICS
[patent_app_type] => utility
[patent_app_number] => 17/373763
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373763
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373763 | CONDUCTIVE SYNTHETIC PEPTIDES FOR MOLECULAR ELECTRONICS | Jan 9, 2020 | Pending |
Array
(
[id] => 17471635
[patent_doc_number] => 20220079139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => CYCLOSPORIN ANALOG AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/423909
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423909 | CYCLOSPORIN ANALOG AND USE THEREOF | Jan 7, 2020 | Abandoned |
Array
(
[id] => 16267410
[patent_doc_number] => 20200268897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => Phosphatase Binding Compounds and Methods of Using Same
[patent_app_type] => utility
[patent_app_number] => 16/737148
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737148
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737148 | Phosphatase Binding Compounds and Methods of Using Same | Jan 7, 2020 | Abandoned |
Array
(
[id] => 15866171
[patent_doc_number] => 20200140489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => Peptide-Based Quorum Sensing Inhibitors for the Attenuation of Virulence in Staphylococcus Aureus
[patent_app_type] => utility
[patent_app_number] => 16/737749
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737749
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737749 | Peptide-Based Quorum Sensing Inhibitors for the Attenuation of Virulence in Staphylococcus Aureus | Jan 7, 2020 | Abandoned |
Array
(
[id] => 19111196
[patent_doc_number] => 20240122946
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-04-18
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING 25-HYDROXYVITAMIN D DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 16/733113
[patent_app_country] => US
[patent_app_date] => 2020-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733113
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/733113 | METHODS AND COMPOSITIONS FOR TREATING 25-HYDROXYVITAMIN D DEFICIENCY | Jan 1, 2020 | Abandoned |
Array
(
[id] => 19111196
[patent_doc_number] => 20240122946
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-04-18
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING 25-HYDROXYVITAMIN D DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 16/733113
[patent_app_country] => US
[patent_app_date] => 2020-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733113
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/733113 | METHODS AND COMPOSITIONS FOR TREATING 25-HYDROXYVITAMIN D DEFICIENCY | Jan 1, 2020 | Abandoned |
Array
(
[id] => 18147657
[patent_doc_number] => 20230021514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => Etelcalcetide intermediate and method for synthesizing etelcalcetide
[patent_app_type] => utility
[patent_app_number] => 17/782200
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782200 | Etelcalcetide intermediate and method for synthesizing etelcalcetide | Dec 26, 2019 | Abandoned |
Array
(
[id] => 15800177
[patent_doc_number] => 20200123231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => COLLAGEN-BASED BIOMATERIAL
[patent_app_type] => utility
[patent_app_number] => 16/727551
[patent_app_country] => US
[patent_app_date] => 2019-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16727551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/727551 | COLLAGEN-BASED BIOMATERIAL | Dec 25, 2019 | Abandoned |
Array
(
[id] => 17532242
[patent_doc_number] => 20220110851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ACETYLCHOLINE RECEPTOR INHIBITORY PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/418494
[patent_app_country] => US
[patent_app_date] => 2019-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418494 | ACETYLCHOLINE RECEPTOR INHIBITORY PEPTIDES AND USES THEREOF | Dec 25, 2019 | Pending |
Array
(
[id] => 18134766
[patent_doc_number] => 11560419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Targeting tumor microenvironments with recombinant prokaryotic collagen-like proteins
[patent_app_type] => utility
[patent_app_number] => 16/725142
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 2833
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/725142 | Targeting tumor microenvironments with recombinant prokaryotic collagen-like proteins | Dec 22, 2019 | Issued |